# Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients

> **NCT02643862** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 48 (actual)

## Conditions studied

- Food Allergy

## Interventions

- **DRUG:** Xolair
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02643862
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-18
- **Primary completion:** 2016-08-20
- **Final completion:** 2016-08-20
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02643862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02643862, "Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT02643862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*